Competing interests
UHS
RC: medical body composition analysers have been provided by SECA to UHS as part of an investigator-led Collaborative Research Agreement between SECA GmbH & Co. KG. (Hamburg, Germany), UHS and the University of Southampton. Also institutional research funding by Astra Zeneca (unrelated to this study). The other authors declare no competing interests.